Literature DB >> 33236704

Providing Ancillary Care in Clinical Research: A Case of Diffuse Large B-Cell Lymphoma during a Malaria Vaccine Trial in Equatorial Guinea.

Stephen R Manock1,2, Ali Mtoro3, Vicente Urbano Nsue Ndong4, Ally Olotu3,5, Mwajuma Chemba3, Antonio E Sama Roca6, Esther Eburi6, Guillermo A García7, Carlos Cortes Falla6, Julie Niemczura de Carvalho7, Jaime Contreras8, Baltasar Saturno8, Juan de Dios Riocalo8, José Luis Nze Mba9, Rima Koka10, Seung Tae Lee10, Hari Menon11, L W Preston Church1, Mitoha Ondo'o Ayekaba4, Peter F Billingsley1, Salim Abdulla3, Thomas L Richie1, Stephen L Hoffman1.   

Abstract

Providing medical care for participants in clinical trials in resource-limited settings can be challenging and costly. Evaluation and treatment of a young man who developed cervical lymphadenopathy during a malaria vaccine trial in Equatorial Guinea required concerted efforts of a multinational, multidisciplinary team. Once a diagnosis of diffuse large B-cell lymphoma was made, the patient was taken to India to receive immunochemotherapy. This case demonstrates how high-quality medical care was provided for a serious illness that occurred during a trial that was conducted in a setting in which positron emission tomography for diagnostic staging, an oncologist for supervision of treatment, and an optimal therapeutic intervention were not available. Clinical researchers should anticipate the occurrence of medical conditions among study subjects, clearly delineate the extent to which health care will be provided, and set aside funds commensurate with those commitments.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33236704      PMCID: PMC7866340          DOI: 10.4269/ajtmh.20-1178

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  1 in total

1.  Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study.

Authors:  Patricia Nicolas; Caroline Kiuru; Martin G Wagah; Martha Muturi; Urs Duthaler; Felix Hammann; Marta Maia; Carlos Chaccour
Journal:  Parasit Vectors       Date:  2021-03-20       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.